Targeting human oligodendrocyte progenitors for myelin repair
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Oligodendrocyte development has been studied for several decades, and has served as a model system for both neurodevelopmental and stem/progenitor cell biology. Until recently, the vast majority of studies have been conducted in lower species, especially those focused on rodent development and remyelination. In humans, the process of myelination requires the generation of vastly more myelinating glia, occurring over a period of years rather than weeks. Furthermore, as evidenced by the presence of chronic demyelination in a variety of human neurologic diseases, it appears likely that the mechanisms that regulate development and become dysfunctional in disease may be, in key ways, divergent across species. Improvements in isolation techniques, applied to primary human neural and oligodendrocyte progenitors from both fetal and adult brain, as well as advancements in the derivation of defined progenitors from human pluripotent stem cells, have begun to reveal the extent of both species-conserved signaling pathways and potential key differences at cellular and molecular levels. In this article, we will review the commonalities and differences in myelin development between rodents and man, describing the approaches used to study human oligodendrocyte differentiation and myelination, as well as heterogeneity within targetable progenitor pools, and discuss the advances made in determining which conserved pathways may be both modeled in rodents and translate into viable therapeutic strategies to promote myelin repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., et al. (2012) · Nature · doi:10.1038/nature11314 · Cited by 1,664 · cited 1×
“Accumulating evidence has established that there are diverse contributions of oligodendrocytes to overall nervous system function (Nave and Werner, 2014), and it has become apparent that oligodendroglia provide key metabolic and trophic support to axons (Lee et al., 2012; Morrison et al., 2013).”
BackgroundBlackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596 · cited 1×
“The role of telomerase and mechanisms by which telomere length are maintained are indeed speciesspecific (Blackburn et al., 2015), but the relevance to oligodendrocyte specification and differentiation remains to be determined.”
BackgroundRemyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 1×
“Several rodent models of demyelination/remyelination have been described (Franklin and Ffrench-Constant, 2008).”
BackgroundThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Computational and analytical challenges in single-cell transcriptomics
Stegle, O., Teichmann, S. A., & Marioni, J. C. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3833 · Cited by 1,170 · cited 2×
“…will no doubt resolve whether OPC subpopulations can be further divided, or if differences within these are largely due to the stochastic differences and the bursting nature of gene transcription at the single cell level, as has been described for similar analyses (Stegle et al., 2015).”
ResultRakic, P. (1974) · Science · doi:10.1126/science.183.4123.425 · Cited by 1,161
Diffusion tensor imaging of white matter tract evolution over the lifespan
Lebel, C., Gee, M., Camicioli, R., Wieler, M., Martin, W., & Beaulieu, C. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.094 · Cited by 1,100
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · cited 4×
“, 2004), use of this model is complicated by systemic effects, including severe weight loss and death (Matsushima and Morell, 2001), as well as pronounced changes in axonal caliber (Mason et al.”
BackgroundMethodInfluentialPDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice
Rivers, L. E., Young, K. M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kessaris, N., & Richardson, W. D. (2008) · Nature Neuroscience · doi:10.1038/nn.2220 · Cited by 961 · cited 3×
“OPCs persist in the adult white matter and cortex and continue to divide throughout life (Dimou et al., 2008; Rivers et al., 2008; Zhu et al., 2011), but appear largely restricted to oligodendrocyte fate in response to injury or demyelination (Dimou et al.”
BackgroundHughes, E. G., Kang, S. H., Fukaya, M., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3390 · Cited by 808
Smart, I. H. M. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.1.37 · Cited by 687 · cited 1×
“Interestingly, the primate subventricular zone (SVZ) undergoes massive expansion compared with the rodent and becomes subdivided into distinct inner and outer regions delineated by cholinergic fibers emanating from the immature lateral geniculate nucleus (Smart et al., 2002).”
BackgroundRejuvenation of Regeneration in the Aging Central Nervous System
Ruckh, J. M., Zhao, J.-W., Shadrach, J. L., van Wijngaarden, P., Rao, T. N., Wagers, A. J., & Franklin, R. J. M. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.11.019 · Cited by 649
Sim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02451.2002 · Cited by 625
Self-citationWang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586 · cited 4×
“However, it appears that the oligodendrocytes generated from CD133defined cells were more likely a result of contaminating CD133+CD140a+ OPCs, rather than from differentiating stem cells (Wang et al., 2013a).”
BackgroundInfluentialWolswijk, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-02-00601.1998 · Cited by 562
Dimou, L., Simon, C., Kirchhoff, F., Takebayashi, H., & Götz, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2831-08.2008 · Cited by 551 · cited 4×
“, 2011), but appear largely restricted to oligodendrocyte fate in response to injury or demyelination (Dimou et al., 2008; Kang et al., 2010; Zawadzka et al., 2010).”
BackgroundInfluentialRetinoid X receptor gamma signaling accelerates CNS remyelination
Huang, J. K., Jarjour, A. A., Nait Oumesmar, B., Kerninon, C., Williams, A., Krezel, W., Kagechika, H., Bauer, J., Zhao, C., Evercooren, A. B.-V., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2702 · Cited by 547
Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain
Yeung, M. S. Y., Zdunek, S., Bergmann, O., Bernard, S., Salehpour, M., Alkass, K., Perl, S., Tisdale, J., Possnert, G., Brundin, L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.011 · Cited by 541 · cited 7×
“In contrast, the majority of human oligodendrocyte generation and myelination occurs over a developmental period of 3–5 years (Nakagawa et al., 1998; Yeung et al., 2014), with linear increases in myelin volume thereafter, occurring from ages 4 to 22 (Giedd et al., 1999).”
BackgroundResultInfluentialA regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways
Miller, J. A., Horvath, S., & Geschwind, D. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914257107 · Cited by 480 · cited 1×
“While the overall gene–gene expression relationships derived from human and mouse forebrain tissues are largely conserved between species, differences are present and remain to be fully characterized (Miller et al., 2010).”
BackgroundAdrenoleukodystrophy: A Clinical and Pathological Study of 17 Cases
Schaumburg, H. H. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510033001 · Cited by 475
Age-dependent fate and lineage restriction of single NG2 cells
Zhu, X., Hill, R. A., Dietrich, D., Komitova, M., Suzuki, R., & Nishiyama, A. (2011) · Development · doi:10.1242/dev.047951 · Cited by 464 · cited 2×
“OPCs persist in the adult white matter and cortex and continue to divide throughout life (Dimou et al., 2008; Rivers et al., 2008; Zhu et al., 2011), but appear largely restricted to oligodendrocyte fate in response to injury or demyelination (Dimou et al.”
BackgroundBetizeau, M., Cortay, V., Patti, D., Pfister, S., Gautier, E., Bellemin-Ménard, A., Afanassieff, M., Huissoud, C., Douglas, R. J., Kennedy, H., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.032 · Cited by 462
Windrem, M. S., Nunes, M. C., Rashbaum, W. K., Schwartz, T. H., Goodman, R. A., McKhann, G., Roy, N. S., & Goldman, S. A. (2004) · Nature Medicine · doi:10.1038/nm974 · Cited by 451 · cited 2×
“However, to avoid contamination with neurogenic progenitors, A2B5+ cells were depleted for PSA-NCAM antigenicity to generate a highly myelinogenic population (Windrem et al., 2004; Windrem et al., 2008).”
BackgroundMethodDrug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Remyelination protects axons from demyelination-associated axon degeneration
Irvine, K. A., & Blakemore, W. F. (2008) · Brain · doi:10.1093/brain/awn080 · Cited by 420 · cited 1×
“Remyelination not only restores saltatory conduction and function (Jeffery and Blakemore, 1997; Smith et al., 1979), but also provides protection to demyelinated axons (Irvine and Blakemore, 2008), possibly by the restoration of trophic support, as well as providing a barrier to noxious stimuli.”
BackgroundbHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS
Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J. M., & Stiles, C. D. (2004) · Science · doi:10.1126/science.1103709 · Cited by 416
Calegari, F., Haubensak, W., Haffner, C., & Huttner, W. B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0778-05.2005 · Cited by 396 · cited 1×
“In addition, the G1 phase of the cell cycle typically lengthens during cortical development (Calegari et al., 2005).”
BackgroundRichardson, W. D., Kessaris, N., & Pringle, N. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1826 · Cited by 385 · cited 8×
“However, in the mouse SVZ, neurogenic and expanding divisions can be distinguished on the basis of a substantially longer S phase in self-renewing division.”
BackgroundInfluentialAxin2 as regulatory and therapeutic target in newborn brain injury and remyelination
Fancy, S. P. J., Harrington, E. P., Yuen, T. J., Silbereis, J. C., Zhao, C., Baranzini, S. E., Bruce, C. C., Otero, J. J., Huang, E. J., Nusse, R., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2855 · Cited by 349 · cited 3×
“In contrast, following mouse spinal cord demyelination, the densities of OPCs are rarely described as <50,000 cells/mm3 (> 800 cells/mm2, 12 µm sections) (Fancy et al., 2009; Fancy et al., 2011b).”
BackgroundFietz, S. A., Lachmann, R., Brandl, H., Kircher, M., Samusik, N., Schröder, R., Lakshmanaperumal, N., Henry, I., Vogt, J., Riehn, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209647109 · Cited by 337 · cited 1×
“…analysis of human and murine fetal neocortex compared immediately following OPC specification indicates that the outer SVZ contains more oligodendrocyte lineage-specific genes (SOX10, OLIG1), suggesting that this primatespecific structure is relatively enriched with OPCs (Fietz et al., 2012).”
BackgroundSimon, C., Götz, M., & Dimou, L. (2011) · Glia · doi:10.1002/glia.21156 · Cited by 313 · cited 1×
“The cell cycle differs between grey and white matter, ranging from 3 to 10 days in the corpus callosum and from 18 to 37 days in the cortex (Psachoulia et al., 2009; Simon et al., 2011; Wang and Young, 2014).”
BackgroundDouvaras, P., Wang, J., Zimmer, M., Hanchuk, S., O’Bara, M. A., Sadiq, S., Sim, F. J., Goldman, J., & Fossati, V. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.06.012 · Cited by 302 · cited 1×
“We have recently followed this study by showing that myelinogenic OPCs can be derived from MS patients' skin cells, demonstrating the feasibility of implanting patient-specific cells for the purposes of remyelination (Douvaras et al., 2014).”
BackgroundSelf-citationMi, S., Miller, R. H., Tang, W., Lee, X., Hu, B., Wu, W., Zhang, Y., Shields, C. B., Zhang, Y., Miklasz, S., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21581 · Cited by 300 · cited 1×
“However, such studies have primarily shown an acceleration of remyelination, rather than induced remyelination of an otherwise chronically demyelinated plaque (for example Deshmukh et al., 2013; Fancy et al., 2011b; Huang et al., 2011; Mei et al., 2014; Mi et al., 2009; Najm et al., 2015).”
BackgroundCell cycle dynamics of NG2 cells in the postnatal and ageing brain
Psachoulia, K., Jamen, F., Young, K. M., & Richardson, W. D. (2009) · Neuron Glia Biology · doi:10.1017/s1740925x09990354 · Cited by 257 · cited 1×
“The cell cycle differs between grey and white matter, ranging from 3 to 10 days in the corpus callosum and from 18 to 37 days in the cortex (Psachoulia et al., 2009; Simon et al., 2011; Wang and Young, 2014).”
BackgroundOrtega, F., Gascón, S., Masserdotti, G., Deshpande, A., Simon, C., Fischer, J., Dimou, L., Chichung Lie, D., Schroeder, T., & Berninger, B. (2013) · Nature Cell Biology · doi:10.1038/ncb2736 · Cited by 247 · cited 2×
“of CD140a/PDGFRα for fetal tissue isolation has become more common in recent years (Moore et al., 2015; Ortega et al., 2013).”
BackgroundWake, H., Ortiz, F. C., Woo, D. H., Lee, P. R., Angulo, M. C., & Fields, R. D. (2015) · Nature Communications · doi:10.1038/ncomms8844 · Cited by 244 · cited 2×
“, 2014), and remyelination is likely to favor active neurons (Gautier et al., 2015; Wake et al., 2015).”
BackgroundQuantifying the early stages of remyelination following cuprizone-induced demyelination
Stidworthy, M. F., Genoud, S., Suter, U., Mantei, N., & Franklin, R. J. M. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00032.x · Cited by 224
Cortical remyelination: A new target for repair therapies in multiple sclerosis
Chang, A., Staugaitis, S. M., Dutta, R., Batt, C. E., Easley, K. E., Chomyk, A. M., Yong, V. W., Fox, R. J., Kidd, G. J., & Trapp, B. D. (2012) · Annals of Neurology · doi:10.1002/ana.23693 · Cited by 216 · cited 1×
“Periplaque and lesion tissues exhibited slightly increased NG2+ cell density relatively to control grey matter, albeit with substantially lower overall density estimates (2000–3000 cells/mm3) compared to the previous two studies (Chang et al., 2012).”
ResultMason, J. L., Toews, A., Hostettler, J. D., Morell, P., Suzuki, K., Goldman, J. E., & Matsushima, G. K. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63726-1 · Cited by 212
Efficient central nervous system remyelination requires T cells
Bieber, A. J., Kerr, S., & Rodriguez, M. (2003) · Annals of Neurology · doi:10.1002/ana.10578 · Cited by 196 · cited 1×
“This is particularly relevant based on the fact that immune cells have been shown to play an important role in remyelination (Bieber et al., 2003; Doring et al., 2015; Miron et al., 2013; Ruckh et al., 2012).”
BackgroundBlakemore, W. F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90119-6 · Cited by 177
Mason, J. L., Langaman, C., Morell, P., Suzuki, K., & Matsushima, G. K. (2001) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2001.00301.x · Cited by 172
Hu, B.-Y., Du, Z.-W., Li, X.-J., Ayala, M., & Zhang, S.-C. (2009) · Development · doi:10.1242/dev.029447 · Cited by 169
Statin Therapy Inhibits Remyelination in the Central Nervous System
Miron, V. E., Zehntner, S. P., Kuhlmann, T., Ludwin, S. K., Owens, T., Kennedy, T. E., Bedell, B. J., & Antel, J. P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080947 · Cited by 141 · cited 2×
“Other studies have shown that the statin drug simvastatin regulates process dynamics and survival of OPCs isolated from fetal human brain (Miron et al., 2007), and can modulate remyelination following cuprizone-induced demyelination (Miron et al., 2009).”
BackgroundVentura-Antunes, L., Mota, B., & Herculano-Houzel, S. (2013) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2013.00003 · Cited by 129
Endogenous cell repair of chronic demyelination
Armstrong, R. C., Le, T. Q., Flint, N. C., Vana, A. C., & Zhou, Y.-X. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000205142.08716.7e · Cited by 125
Human myelin proteome and comparative analysis with mouse myelin
Ishii, A., Dutta, R., Wark, G. M., Hwang, S.-I., Han, D. K., Trapp, B. D., Pfeiffer, S. E., & Bansal, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905936106 · Cited by 119
Plasmalogens participate in very-long-chain fatty acid-induced pathology
Brites, P., Mooyer, P. A. W., el Mrabet, L., Waterham, H. R., & Wanders, R. J. A. (2008) · Brain · doi:10.1093/brain/awn295 · Cited by 112
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation
Wang, J., Pol, S. U., Haberman, A. K., Wang, C., O’Bara, M. A., & Sim, F. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408295111 · Cited by 79
Self-citationLamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model
Heng, M. Y., Lin, S.-T., Verret, L., Huang, Y., Kamiya, S., Padiath, Q. S., Tong, Y., Palop, J. J., Huang, E. J., Ptácχek, L. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66737 · Cited by 78 · cited 3×
“Several genetic models for leukodystrophies seem to closely model the pathologies observed in humans, such as mice deficient in Aspa for Canavan disease (Matalon et al., 2000) and overexpressing Lmnb1 for adult-onset autosomal-dominant leukodystrophy (Heng et al., 2013).”
Background
Cited by
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647
Stem cell derived oligodendrocytes to study myelin diseases
Chanoumidou, K., Mozafari, S., Baron‐Van Evercooren, A., & Kuhlmann, T. (2020) · Glia · doi:10.1002/glia.23733 · Cited by 62
Marangon, D., Caporale, N., Boccazzi, M., Abbracchio, M. P., Testa, G., & Lecca, D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.748849 · Cited by 34
Levy, M. J. F., Garcia-Diaz, B., Sedel, F., Baron-Van Evercooren, A., & Mozafari, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415733 · Cited by 7
“While the delayed cell cycle exit of hOPC may have slowed down their myelination process, it would not be the case for murine OPCs since they resume their proliferation within the first postnatal month [44,45].”
Background
Metadata
- Authors
- Dietz, K. C., Polanco, J. J., Pol, S. U., & Sim, F. J.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 283
- Issue
- Pt B
- Pages
- 489-500
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W2298588974
- Cited by
- 55
- References
- 53
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.